Peter Hildenbrand
- Pathology and Forensic Medicine top 5%
- Neurology top 5%
- Radiology, Nuclear Medicine and Imaging top 10%
- Epidemiology
- Ophthalmology top 5%
- Co-authors
- D. E. CravenRobert JonesCharles R.G. GuttmannMaurício CastilloNancy J. FischbeinJames A. FeeB. WrightEdward P. Quigley
- Topics
- Multiple Sclerosis Research Studies (5 papers)Glioma Diagnosis and Treatment (3 papers)Cerebrospinal fluid and hydrocephalus (3 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Peter Hildenbrand
25 papers receiving 690 citations
Peers
Comparison fields: 5 of 98
- Pathology and Forensic Medicine 297
- Neurology 221
- Radiology, Nuclear Medicine and Imaging 113
- Epidemiology 92
- Ophthalmology 84
Countries citing papers authored by Peter Hildenbrand
This map shows the geographic impact of Peter Hildenbrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hildenbrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hildenbrand more than expected).
Fields of papers citing papers by Peter Hildenbrand
This network shows the impact of papers produced by Peter Hildenbrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hildenbrand. The network helps show where Peter Hildenbrand may publish in the future.
Co-authorship network of co-authors of Peter Hildenbrand
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hildenbrand. A scholar is included among the top collaborators of Peter Hildenbrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hildenbrand. Peter Hildenbrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 34 | |
| 3 | 70 | |
| 4 | 199 | |
| 5 | 28 | |
| 6 | 111 | |
| 7 | 54 | |
| 8 | 10 | |
| 9 | 4 | |
| 10 | 15 | |
| 11 | 28 | |
| 12 | 37 | |
| 13 | 2 | |
| 14 | 8 | |
| 15 | Radiology of primary intracranial yolk-sac (endodermal sinus) tumors. | 3 |
| 16 | 12 | |
| 17 | 3 | |
| 18 | 7 | |
| 19 | 8 | |
| 20 | 43 |
About Peter Hildenbrand
Peter Hildenbrand is a scholar working on Pathology and Forensic Medicine, Genetics and Internal Medicine, having authored 26 papers that have together received 721 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (5 papers), Glioma Diagnosis and Treatment (3 papers) and Cerebrospinal fluid and hydrocephalus (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (297 citations), Neurology (221 citations) and Parasitology (71 citations). Peter Hildenbrand has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include D. E. Craven, Robert Jones, Charles R.G. Guttmann, Maurício Castillo, Nancy J. Fischbein, James A. Fee, B. Wright, Edward P. Quigley, A.G. Osborn and Christine M. Glastonbury. Their work appears in journals such as Neurology, FEBS Letters and Journal of Neurology Neurosurgery & Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.